Literature DB >> 10715599

The tachycardia-induced dog model of atrial fibrillation. clinical relevance and comparison with other models.

R Gaspo1.   

Abstract

In the past, investigators have relied extensively on acute in vivo models of atrial fibrillation (AF), in which AF was induced either pharmacologicly or by vagal stimulation. More recently, there is a need and desire for more clinically relevant models that can only be achieved with the use of chronically instrumented animals. One of these models is the atrial tachycardia-induced AF dog model, which is the main focus of this review. The model produces a persistent AF in 80% of animals paced at 400 beats/min for 6 weeks. Atrial tachycardia also induces various pathophysiologic and ultrastructural changes that often resemble electrical remodeling of atria in patients that have a high susceptibility to AF. This model can also be used to evaluate drug efficacy with respect to attenuation of AF duration or conversion of AF to sinus rhythm. The model may therefore be used to provide further insights into the discovery of new therapeutic approaches to modifying this atrial arrhythmic disorder in man.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10715599     DOI: 10.1016/s1056-8719(99)00042-8

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

1.  Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

Authors:  Maryse Palardy; Anique Ducharme; Stanley Nattel; Jean-Claude Tardif; Michel White; Normand Racine; Karine Tétreault; Farida Dabouz; Mario Talajic; Denis Roy
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

2.  Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs.

Authors:  Derek J Dosdall; Ravi Ranjan; Koji Higuchi; Eugene Kholmovski; Nathan Angel; Li Li; Rob Macleod; Layne Norlund; Aaron Olsen; Christopher J Davies; Nassir F Marrouche
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-28       Impact factor: 4.733

3.  Role of atrial fibrillation threshold evaluation on guiding treatment.

Authors:  Takeshi Shirayama
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

4.  Structural defects lead to dynamic entrapment in cardiac electrophysiology.

Authors:  Oliver R J Bates; Bela Suki; Peter S Spector; Jason H T Bates
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

5.  miR‑101a‑3p overexpression prevents acetylcholine‑CaCl2‑induced atrial fibrillation in rats via reduction of atrial tissue fibrosis, involving inhibition of EZH2.

Authors:  Jing Zhu; Ning Zhu; Jian Xu
Journal:  Mol Med Rep       Date:  2021-08-26       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.